SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al.Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial.Lancet2004;364:2639.
  • 2
    Verstappen SM, Jacobs JW, van der Veen MJ, Heurkens AH, Schenk Y, ter Borg EJ, et al, on the behalf of the Utrecht Rheumatoid Arthritis Cohort study group.Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial).Ann Rheum Dis2007;66:14439.
  • 3
    Fransen J, Moens HB, Speyer I, van Riel PL.Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial.Ann Rheum Dis2005;64:12948.
  • 4
    Mottonen T, Hannonen P, Korpela M, Nissila M, Kautiainen H, Ilonen J, et al, for the FIN-RACo Trial Group.Delay to institution of therapy and induction of remission using single-drug or combination–disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.Arthritis Rheum2002;46:8948.
  • 5
    Saunders SA, Capell HA, Stirling A, Vallance R, Kincaid W, McMahon AD, et al.Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies.Arthritis Rheum2008;58:13107.
  • 6
    Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al.Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial.Ann Intern Med2007;146:40615.
  • 7
    Symmons D, Tricker K, Roberts C, Davies L, Dawes P, Scott DL.The British Rheumatoid Outcome Study Group (BROSG) randomised controlled trial to compare the effectiveness and cost-effectiveness of aggressive versus symptomatic therapy in established rheumatoid arthritis.Health Technol Assess2005;9:iiiiv,ix–x,1–78.
  • 8
    Genovese MC, Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, et al.Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes.Arthritis Rheum2002;46:144350.
  • 9
    Bathon JM, Martin RW, Fleischmann RM, Tesser JR, Schiff MH, Keystone EC, et al.A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis.N Engl J Med2000;30:158693.
  • 10
    Van Tuyl LH, Lems WF, Voskuyl AE, Kerstens PJ, Garnero P, Dijkmans BA, et al.Tight control and intensified COBRA combination treatment in early rheumatoid arthritis: 90% remission in a pilot trial.Ann Rheum Dis2008;67:15747.
  • 11
    Schoels M, Wong J, Scott DL, Zink A, Richards P, Landewe R, et al.Economic aspects of treatment options in rheumatoid arthritis: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.Ann Rheum Dis2010;69:9951003.
  • 12
    Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al.Treating rheumatoid arthritis to target: recommendations of an international task force.Ann Rheum Dis2010;69:6317.
  • 13
    Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al.2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.Arthritis Care Res (Hoboken)2012;64:62539.
  • 14
    Garber AJ.Treat-to-target trials: uses, interpretation and review of concepts.Diabetes Obes Metab2013. E-pub ahead of print.
  • 15
    Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al.Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.N Engl J Med2005;353:264353.
  • 16
    United Kingdom Prospective Diabetes Study Group.United Kingdom Prospective Diabetes Study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years.BMJ1995;310:838.
  • 17
    Anderson SC, Jones WN, Evanko TM.Dosage of beta-adrenergic blockers after myocardial infarction.Am J Health Syst Pharm2003;60:24714.
  • 18
    New JP, Mason JM, Freemantle N, Teasdale S, Wong LM, Bruce NJ, et al.Specialist nurse-led intervention to treat and control hypertension and hyperlipidemia in diabetes (SPLINT): a randomized controlled trial.Diabetes Care2003;26:22505.
  • 19
    Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al.Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.Lancet2005;366:126778.
  • 20
    Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.Circulation2004;110:22739.
  • 21
    Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F, Buse JB, Goff DC Jr, et al.Long-term effects of intensive glucose lowering on cardiovascular outcomes.N Engl J Med2011;364:81828.
  • 22
    Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, et al.Clinical inertia.Ann Intern Med2001;135:82534.
  • 23
    Schmajuk G, Trivedi AN, Solomon DH, Yelin E, Trupin L, Chakravarty EF, et al.Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans.JAMA2011;305:4806.
  • 24
    American College of Rheumatology Committee on Rheumatology Training and Workforce Issues.Regional distribution of adult rheumatologists.Arthritis Rheum2013;65:301725.
  • 25
    Schmajuk G, Schneeweiss S, Katz JN, Weinblatt ME, Setoguchi S, Avorn J, et al.Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal.Arthritis Rheum2007;57:92834.
  • 26
    Lacaille D, Anis AH, Guh DP, Esdaile JM.Gaps in care for rheumatoid arthritis: a population study.Arthritis Rheum2005;53:2418.
  • 27
    Widdifield J, Bernatsky S, Paterson JM, Thorne JC, Cividino A, Pope J, et al.Quality care in seniors with new-onset rheumatoid arthritis: a Canadian perspective.Arthritis Care Res (Hoboken)2011;63:537.
  • 28
    Wolfe F, Michaud K.Resistance of rheumatoid arthritis patients to changing therapy: discordance between disease activity and patients' treatment choices.Arthritis Rheum2007;56:213542.
  • 29
    Barton JL, Imboden J, Graf J, Glidden D, Yelin EH, Schillinger D.Patient-physician discordance in assessments of global disease severity in rheumatoid arthritis.Arthritis Care Res (Hoboken)2010;62:85764.
  • 30
    Barnett AH.Treating to goal: challenges of current management.Eur J Endocrinol2004;151 Suppl 2:T37.
  • 31
    Fraenkel L, Cunningham M.High disease activity may not be sufficient to escalate care.Arthritis Care Res (Hoboken)2013. E-pub ahead of print.
  • 32
    Curtis JR, Shan Y, Harrold L, Zhang J, Greenberg JD, Reed GW.Patient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomes.Arthritis Care Res (Hoboken)2013;65:170712.
  • 33
    De Wit MP, Smolen JS, Gossec L, van der Heijde DM.Treating rheumatoid arthritis to target: the patient version of the international recommendations.Ann Rheum Dis2011;70:8915.
  • 34
    O'Kane MJ, Bunting B, Copeland M, Coates VE.Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial.BMJ2008;336:11747.
  • 35
    Bitton A.Self-monitoring of blood glucose: depressingly not helpful in the newly diagnosed.J Clin Outcomes Manage2008;15:3189.
  • 36
    Mottonen T, Hannonen P, Leirisalo-Repo M, Nissila M, Kautiainen H, Korpela M, et al, for the FIN-RACo Trial Group.Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial.Lancet1999;353:156873.